{"id":"ertapenem-sodium-mk0826","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Diarrhea"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1232","moleculeType":"Small molecule","molecularWeight":"497.51"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, resulting in the disruption of the cell wall synthesis and ultimately leading to bacterial cell death.","oneSentence":"Ertapenem sodium is a carbapenem antibiotic that inhibits bacterial cell wall synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:11:24.803Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Complicated skin and skin structure infections"},{"name":"Complicated intra-abdominal infections"},{"name":"Community-acquired pneumonia"}]},"trialDetails":[{"nctId":"NCT04886284","phase":"PHASE2","title":"Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia","status":"RECRUITING","sponsor":"Todd C. Lee MD MPH FIDSA","startDate":"2024-05-20","conditions":"Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis","enrollment":60},{"nctId":"NCT06537609","phase":"NA","title":"A Platform Trial for Gram Negative Bloodstream Infections","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-04-24","conditions":"Gram-negative Bacteremia","enrollment":2500},{"nctId":"NCT07376889","phase":"PHASE4","title":"Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia","status":"NOT_YET_RECRUITING","sponsor":"Intermountain Health Care, Inc.","startDate":"2026-02-01","conditions":"Staphylococcus Aureus Bacteremia","enrollment":2096},{"nctId":"NCT07318584","phase":"PHASE2","title":"Cefotetan Therapy for Escherichia Coli Infections","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-03","conditions":"E Coli Infection, ESBL Producing E.Coli","enrollment":84},{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT01543334","phase":"","title":"Antibiotic Concentrations Among Critically Ill Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2012-03","conditions":"Administration of Antibiotics in Intensive Care Units","enrollment":98},{"nctId":"NCT07148960","phase":"PHASE4","title":"Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?","status":"ENROLLING_BY_INVITATION","sponsor":"West Virginia University","startDate":"2025-09-15","conditions":"Staphylococcus Aureus Bacteremia","enrollment":300},{"nctId":"NCT02041767","phase":"PHASE4","title":"Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-12","conditions":"Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection","enrollment":20},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT04502095","phase":"PHASE4","title":"Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2020-09-02","conditions":"Bladder Carcinoma, Refractory Bladder Carcinoma, Urinary Tract Infection","enrollment":89},{"nctId":"NCT06920147","phase":"PHASE4","title":"PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-05-01","conditions":"Surgical Site Infection","enrollment":300},{"nctId":"NCT05645757","phase":"PHASE1","title":"Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-04-19","conditions":"Bacterial Infection","enrollment":54},{"nctId":"NCT06739382","phase":"PHASE3","title":"Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2021-01-01","conditions":"Ventilation Acquired Pneumonia","enrollment":64},{"nctId":"NCT06044272","phase":"","title":"Antimicrobial Resistance in Hospitals From Meta, Colombia","status":"COMPLETED","sponsor":"Hospital Departamental de Villavicencio","startDate":"2023-09-01","conditions":"Increased Drug Resistance","enrollment":10000},{"nctId":"NCT03891433","phase":"PHASE4","title":"Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae","status":"SUSPENDED","sponsor":"Universidad del Norte","startDate":"2019-04-01","conditions":"Urinary Tract Infections, Enterobacteriaceae Infections, Infection Due to ESBL Bacteria","enrollment":198},{"nctId":"NCT05893147","phase":"NA","title":"BALANCE+ Vanguard Phase","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-08-26","conditions":"Gram-negative Bacteremia","enrollment":174},{"nctId":"NCT05224401","phase":"PHASE3","title":"Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs","status":"RECRUITING","sponsor":"Lund University","startDate":"2023-05-29","conditions":"Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection","enrollment":330},{"nctId":"NCT05896930","phase":"PHASE2","title":"Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis","status":"COMPLETED","sponsor":"TASK Applied Science","startDate":"2017-11-09","conditions":"Pulmonary Tuberculosis","enrollment":134},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":"Appendicitis","enrollment":1552},{"nctId":"NCT03925402","phase":"","title":"Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia","status":"COMPLETED","sponsor":"Phramongkutklao College of Medicine and Hospital","startDate":"2019-05-15","conditions":"Bacteremia, Infection, Bacterial","enrollment":427},{"nctId":"NCT02729116","phase":"PHASE2, PHASE3","title":"Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients","status":"UNKNOWN","sponsor":"Khon Kaen University","startDate":"2016-07","conditions":"Anti-Infective Agents, Urinary, Escherichia Coli Infections, Klebsiella Infections","enrollment":30},{"nctId":"NCT03218800","phase":"PHASE3","title":"Ertapenem Administered Subcutaneously Versus Intravenously","status":"TERMINATED","sponsor":"Instituto Nacional de Cancer, Brazil","startDate":"2017-06-01","conditions":"Urinary Tract Infections","enrollment":30},{"nctId":"NCT03788967","phase":"PHASE3","title":"Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Spero Therapeutics","startDate":"2019-06-03","conditions":"Complicated Urinary Tract Infection, Acute Pyelonephritis","enrollment":1372},{"nctId":"NCT02724410","phase":"NA","title":"Role of Intravenous Versus Home Oral Antibiotics in Perforated Appendicitis","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2011-01","conditions":"Perforated Appendicitis","enrollment":82},{"nctId":"NCT04748120","phase":"NA","title":"Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2020-12-28","conditions":"Covid19, Appendicitis, Cholecystitis, Acute","enrollment":2},{"nctId":"NCT05255575","phase":"","title":"A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa","status":"WITHDRAWN","sponsor":"Henry Ford Health System","startDate":"2018-03-01","conditions":"Hidradenitis Suppurativa","enrollment":""},{"nctId":"NCT01844856","phase":"PHASE3","title":"Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2013-08","conditions":"Complicated Intra-abdominal Infections","enrollment":541},{"nctId":"NCT03032510","phase":"PHASE3","title":"Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2017-01","conditions":"Complicated Urinary Tract Infections","enrollment":1205},{"nctId":"NCT01265784","phase":"PHASE2","title":"Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections","status":"COMPLETED","sponsor":"Tetraphase Pharmaceuticals, Inc","startDate":"2011-01","conditions":"Complicated Intra-abdominal Infection","enrollment":143},{"nctId":"NCT03294395","phase":"PHASE3","title":"New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea","status":"COMPLETED","sponsor":"Public Health Service of Amsterdam","startDate":"2017-09-18","conditions":"Gonorrhea","enrollment":346},{"nctId":"NCT04879030","phase":"PHASE2, PHASE3","title":"Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD","status":"COMPLETED","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2020-01-01","conditions":"COPD Exacerbation Acute","enrollment":170},{"nctId":"NCT03357614","phase":"PHASE3","title":"Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults","status":"COMPLETED","sponsor":"Iterum Therapeutics, International Limited","startDate":"2018-09-18","conditions":"Complicated Urinary Tract Infections","enrollment":1395},{"nctId":"NCT04671290","phase":"","title":"Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae","status":"COMPLETED","sponsor":"Centre Hospitalier Annecy Genevois","startDate":"2015-01-01","conditions":"Urinary Tract Infection Bacterial","enrollment":144},{"nctId":"NCT03358576","phase":"PHASE3","title":"Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)","status":"COMPLETED","sponsor":"Iterum Therapeutics, International Limited","startDate":"2018-09-18","conditions":"Intra Abdominal Infections","enrollment":674},{"nctId":"NCT03236961","phase":"NA","title":"Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Turku University Hospital","startDate":"2017-04-03","conditions":"Acute Appendicitis","enrollment":552},{"nctId":"NCT03257423","phase":"NA","title":"Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2017-04-04","conditions":"Acute Appendicitis","enrollment":200},{"nctId":"NCT03234296","phase":"NA","title":"Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis","status":"ENROLLING_BY_INVITATION","sponsor":"Turku University Hospital","startDate":"2017-08-09","conditions":"Acute Appendicitis","enrollment":147},{"nctId":"NCT04505683","phase":"PHASE2, PHASE3","title":"A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)","status":"COMPLETED","sponsor":"Sihuan Pharmaceutical Holdings Group Ltd.","startDate":"2018-12-13","conditions":"Complicated Urinary Tract Infection Including Acute Pyelonephritis","enrollment":112},{"nctId":"NCT02795949","phase":"PHASE3","title":"Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2016-10","conditions":"Enterobacteriaceae Infections","enrollment":344},{"nctId":"NCT04229498","phase":"","title":"Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae","status":"UNKNOWN","sponsor":"SCARE (Study group for carbapenem resistance)","startDate":"2020-04","conditions":"Bloodstream Infection","enrollment":300},{"nctId":"NCT03080103","phase":"","title":"Appendectomy Versus Conservative Treatment for Uncomplicated Acute Appendicitis","status":"COMPLETED","sponsor":"Mauro Podda","startDate":"2017-06-01","conditions":"Acute Appendicitis, Appendicitis Recurrent, Appendectomy","enrollment":300},{"nctId":"NCT04140578","phase":"PHASE4","title":"Antibiotic Prophylaxis in Patients Undergoing GVO","status":"RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2017-01-28","conditions":"Gastric Varix, Sepsis, Liver Cirrhoses","enrollment":150},{"nctId":"NCT03582007","phase":"PHASE3","title":"Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas","status":"TERMINATED","sponsor":"Polyphor Ltd.","startDate":"2018-10-22","conditions":"Pneumonia","enrollment":2},{"nctId":"NCT03859362","phase":"PHASE4","title":"Ertapenem in Patients With Urosepsis","status":"UNKNOWN","sponsor":"Prince of Songkla University","startDate":"2017-01","conditions":"Patients With Urosepis and Received Ertapenem for Treatment","enrollment":12},{"nctId":"NCT02159859","phase":"PHASE2","title":"Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients","status":"COMPLETED","sponsor":"Corewell Health East","startDate":"2014-12","conditions":"End Stage Renal Disease","enrollment":7},{"nctId":"NCT01723150","phase":"PHASE4","title":"Antibiotics for Klebsiella Liver Abscess Study","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2013-11-05","conditions":"Liver Abscess, Pyogenic","enrollment":152},{"nctId":"NCT01370616","phase":"PHASE3","title":"Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-09-02","conditions":"Infection; Diabetic Foot","enrollment":565},{"nctId":"NCT01022567","phase":"NA","title":"Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2009-11","conditions":"Acute Appendicitis","enrollment":530},{"nctId":"NCT02447224","phase":"EARLY_PHASE1","title":"Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis","status":"COMPLETED","sponsor":"Olive View-UCLA Education & Research Institute","startDate":"2015-03","conditions":"Acute Uncomplicated Appendicitis","enrollment":30},{"nctId":"NCT01069900","phase":"PHASE3","title":"Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-07-21","conditions":"Intraabdominal Infections","enrollment":458},{"nctId":"NCT01730664","phase":"PHASE2","title":"PK/PD of Ertapenem In Patients With TB","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2017-01-26","conditions":"PK of Ertapenem in TB Patients","enrollment":12},{"nctId":"NCT03245879","phase":"NA","title":"Antibiotic Stewardship in Small Hospitals","status":"COMPLETED","sponsor":"Intermountain Health Care, Inc.","startDate":"2013-07","conditions":"Inappropriate Prescribing, Antibiotic Stewardship, Anti-Bacterial Agents","enrollment":30000},{"nctId":"NCT01014013","phase":"PHASE3","title":"Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-04","conditions":"Urinary Tract Infection","enrollment":271},{"nctId":"NCT01254344","phase":"PHASE3","title":"Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-12","conditions":"Infection, Surgical Site Infection","enrollment":599},{"nctId":"NCT00771316","phase":"PHASE3","title":"Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-12","conditions":"Urinary Tract Infections","enrollment":6},{"nctId":"NCT00481702","phase":"PHASE3","title":"A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-12","conditions":"Intra-abdominal Infection","enrollment":300},{"nctId":"NCT00157898","phase":"PHASE4","title":"A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-01","conditions":"Complicated Intra-abdominal Infection","enrollment":134},{"nctId":"NCT00451386","phase":"PHASE2","title":"Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-01","conditions":"Urinary Tract Infections, Bacterial Pneumonia, Soft Tissue Infections","enrollment":400},{"nctId":"NCT00389987","phase":"PHASE3","title":"Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-09","conditions":"Complicated Intra-Abdominal Infections","enrollment":300},{"nctId":"NCT00379951","phase":"PHASE3","title":"A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-06","conditions":"Urinary Tract Infection","enrollment":107},{"nctId":"NCT00229112","phase":"PHASE3","title":"Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-04","conditions":"Foot Infections in Diabetic Patients","enrollment":400},{"nctId":"NCT00398099","phase":"PHASE3","title":"To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-07","conditions":"Infection, Pneumonia, Urinary Tract Infection","enrollment":30},{"nctId":"NCT00090272","phase":"PHASE3","title":"A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-04","conditions":"Colorectal Surgery","enrollment":952},{"nctId":"NCT00092170","phase":"PHASE2","title":"An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-03","conditions":"Infections, Pelvic Infections","enrollment":100},{"nctId":"NCT00535652","phase":"PHASE4","title":"Concentration of Ertapenem in Colorectal Tissue","status":"COMPLETED","sponsor":"University of Ulm","startDate":"2007-09","conditions":"Diverticulosis, Colonic, Rectal Neoplasms, Colonic Neoplasms","enrollment":23},{"nctId":"NCT01407965","phase":"PHASE4","title":"Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.","status":"COMPLETED","sponsor":"University of Ulm","startDate":"2012-04","conditions":"Obesity","enrollment":13},{"nctId":"NCT02505386","phase":"PHASE4","title":"Pharmacokinetics of Ertapenem in Patients Aged Over 75","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2014-08","conditions":"Infections","enrollment":27},{"nctId":"NCT02789865","phase":"PHASE2","title":"Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2016-05","conditions":"Acute Appendicitis","enrollment":240},{"nctId":"NCT00397956","phase":"PHASE3","title":"To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-09","conditions":"Sepsis","enrollment":30},{"nctId":"NCT02537847","phase":"PHASE2","title":"Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2012-11","conditions":"Infection Due to Escherichia Coli, Acute Pyelonephritis","enrollment":96},{"nctId":"NCT01587495","phase":"PHASE1","title":"Pharmacokinetics and Safety of Ertapenem in the Postpartum Period","status":"TERMINATED","sponsor":"Daniel Benjamin","startDate":"2012-03","conditions":"Endometritis","enrollment":3},{"nctId":"NCT01703299","phase":"","title":"Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-10","conditions":"Carbapenem-induced Resistance","enrollment":35},{"nctId":"NCT00492726","phase":"PHASE3","title":"Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-07","conditions":"Infection","enrollment":804},{"nctId":"NCT01421901","phase":"PHASE4","title":"Antibiotics Versus Surgery in Acute Appendicitis","status":"UNKNOWN","sponsor":"A.O. Ospedale Papa Giovanni XXIII","startDate":"2011-08","conditions":"Acute Appendicitis Without Peritonitis","enrollment":218},{"nctId":"NCT01173068","phase":"","title":"An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2010-08","conditions":"Urinary Tract Infections","enrollment":60},{"nctId":"NCT00489138","phase":"PHASE4","title":"Prospective, Open-label Study of Pharmacokinetics of Ertapenem in the Muscle Using Microdialysis in Mechanically Ventilated Intensive Care Unit Patients, Treated or Not by Norepinephrine","status":"TERMINATED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2007-04","conditions":"To Assess the Tissular and Plasma Kinetics of Ertapenem","enrollment":9},{"nctId":"NCT01937832","phase":"PHASE3","title":"A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2013-10","conditions":"Community Acquired Pneumonia","enrollment":540},{"nctId":"NCT01886053","phase":"PHASE2","title":"A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2011-04","conditions":"Community Acquired Pneumonia","enrollment":189},{"nctId":"NCT00939952","phase":"PHASE4","title":"Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis","status":"COMPLETED","sponsor":"Albany College of Pharmacy and Health Sciences","startDate":"2009-06","conditions":"Continuous Ambulatory Peritoneal Dialysis, End Stage Renal Disease","enrollment":7},{"nctId":"NCT01725841","phase":"","title":"The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2009-04","conditions":"Enterobacteriaceae Infections","enrollment":300},{"nctId":"NCT01497990","phase":"PHASE4","title":"Pharmacokinetics Ertapenem Burns","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2010-01","conditions":"Burn Patients","enrollment":8},{"nctId":"NCT00877370","phase":"PHASE4","title":"Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2009-02","conditions":"Acute Kidney Failure","enrollment":8},{"nctId":"NCT01061047","phase":"PHASE1","title":"Comparison of Ertapenem Distribution in the Muscle of Six Healthy Volunteers and Six Critically Ill Patients by Microdialysis","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT01203046","phase":"PHASE2, PHASE3","title":"Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days","status":"COMPLETED","sponsor":"Silvia M. Pinango L.","startDate":"2010-12","conditions":"SURGICAL SITE INFECTION","enrollment":56},{"nctId":"NCT01611025","phase":"","title":"Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2011-06","conditions":"Infectious Diseases","enrollment":30000},{"nctId":"NCT01148771","phase":"PHASE4","title":"Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2010-08","conditions":"Healthy","enrollment":12},{"nctId":"NCT01297842","phase":"PHASE4","title":"Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2011-05","conditions":"Drug Safety","enrollment":100},{"nctId":"NCT00630513","phase":"PHASE4","title":"T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam","status":"COMPLETED","sponsor":"University of Bologna","startDate":"2008-01","conditions":"Intra-Abdominal Infection","enrollment":142},{"nctId":"NCT00658866","phase":"PHASE4","title":"Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2008-02","conditions":"Soft Tissue Infection","enrollment":10},{"nctId":"NCT01159379","phase":"PHASE4","title":"Safety of Ertapenem in Beta-lactam Allergic Patients.","status":"UNKNOWN","sponsor":"Catholic University of the Sacred Heart","startDate":"2011-01","conditions":"IgE-Mediated Hypersensitivity, Allergy","enrollment":30},{"nctId":"NCT01073059","phase":"PHASE1","title":"Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Subjects","status":"COMPLETED","sponsor":"Chonbuk National University","startDate":"2009-08","conditions":"Healthy","enrollment":10},{"nctId":"NCT00366249","phase":"PHASE3","title":"Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2007-01","conditions":"Bacterial Infections, Diabetic Foot, Osteomyelitis","enrollment":1061},{"nctId":"NCT00392028","phase":"NA","title":"Penetration of Ertapenem Into Bone","status":"WITHDRAWN","sponsor":"HaEmek Medical Center, Israel","startDate":"2006-11","conditions":"Amputation","enrollment":12},{"nctId":"NCT00097734","phase":"PHASE4","title":"Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis","status":"UNKNOWN","sponsor":"Klinikum Hanover-Siloah Hospital","startDate":"2004-07","conditions":"Diverticulitis, Colonic, Acute Disease","enrollment":540}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MK0826"],"phase":"phase_3","status":"active","brandName":"ertapenem sodium (MK0826)","genericName":"ertapenem sodium (MK0826)","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ertapenem sodium is a carbapenem antibiotic that inhibits bacterial cell wall synthesis. Used for Complicated skin and skin structure infections, Complicated intra-abdominal infections, Community-acquired pneumonia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}